posted on 2018-01-08, 00:00authored byYohan Lee, Hyun-Ro Lee, KyuHan Kim, Siyoung Q. Choi
Because
numerous drugs are administered through an oral route and
primarily absorbed at the intestine, the prediction of drug permeability
across an intestinal epithelial cell membrane has been a crucial issue
in drug discovery. Thus, various in vitro permeability
assays have been developed such as the Caco-2 assay, the parallel
artificial membrane permeability assay (PAMPA), the phospholipid vesicle-based
permeation assays (PVPA) and Permeapad. However, because of the time-consuming
and quite expensive process for culturing cells in the Caco-2 assay
and the unknown microscopic membrane structures of the other assays,
a simpler yet more accurate and versatile technique is still required.
Accordingly, we developed a new platform to measure the permeability
of small molecules across a planar freestanding lipid bilayer with
a well-defined area and structure. The lipid bilayer was constructed
within a conventional UV spectrometer cell, and the transport of drug
molecules across the bilayer was recorded by UV absorbance over time.
We then computed the permeability from the time-dependent diffusion
equation. We tested this assay for five exemplary hydrophilic drugs
and compared their values with previously reported ones. We found
that our assay has a much higher permeability compared to the other
techniques, and this higher permeability is related to the thickness
of the lipid bilayer. Also we were able to measure the dynamic permeability
upon the addition of a membrane-disrupting surfactant demonstrating
that our assay has the capability to detect real-time changes in permeability
across the lipid bilayer.